Scott Mcnear Thacher
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.0MFederal grants as PI6 awards
0Patents grantedNone matched
51Papers1,913 citations
Federal awards and patents by year
AwardsPatents
6 awards · $4.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 16, 2025 | NIH | SBIR Phase II A novel, pleiotropic oral drug class that inhibits gut migration of activated T cells | $634K | ORPHAGEN PHARMACEUTICALS, INC. |
| Sep 5, 2024 | NIH | SBIR Phase II A novel, pleiotropic oral drug class that inhibits gut migration of activated T cells | $1.1M | ORPHAGEN PHARMACEUTICALS, INC. |
| Jun 30, 2022 | NIH | SBIR Phase II Preclinical development of OR-449, a novel targeted therapy for adrenocortical cancer | $693K | ORPHAGEN PHARMACEUTICALS, INC. |
| Jul 5, 2021 | NIH | SBIR Phase II Preclinical development of OR-449, a novel targeted therapy for adrenocortical cancer | $1.3M | ORPHAGEN PHARMACEUTICALS, INC. |
| Jul 25, 2016 | NIH | SBIR Phase I HLS-Small Molecule Discovery at Novel Target for Fetal Hemoglobin Induction | $161K | ORPHAGEN PHARMACEUTICALS, INC. |
| Aug 18, 2015 | NIH | SBIR Phase I HLS-Small Molecule Discovery at Novel Target for Fetal Hemoglobin Induction | $164K | ORPHAGEN PHARMACEUTICALS, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#385
Awards as PI#315
Patents#273
Companies
- ORPHAGEN PHARMACEUTICALS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.